Evidence map›Paper›PMID 35049648›Full record

ReviewBiosensors2021

Microfluidic-Based Droplets for Advanced Regenerative Medicine: Current Challenges and Future Trends.

Hojjatollah Nazari, Asieh Heirani-Tabasi, Sadegh Ghorbani, Hossein Eyni, Sajad Razavi Bazaz, Maryam Khayati, Fatemeh Gheidari, Keyvan Moradpour, Mousa Kehtari, Seyed Mohsen Ahmadi Tafti and 2 more

Abstract readReview
In one paragraph

Review in Biosensors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Droplets microfluidics platform-A tool for single cell research.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hojjatollah NazariSchool of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
Asieh Heirani-TabasiResearch Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center Hospital, Tehran University of Medical Sciences, Tehran 14535, Iran.
Sadegh GhorbaniInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-9591-7721
Hossein EyniCellular and Molecular Research Center, School of Medicine, Iran University of Medical Sciences, Tehran 14535, Iran.
Sajad Razavi BazazSchool of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.ORCID 0000-0002-6419-3361
Maryam KhayatiDepartment of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan 45371, Iran.
Fatemeh GheidariDepartment of Biotechnology, University of Tehran, Tehran 14535, Iran.
Keyvan MoradpourDepartment of Chemical Engineering, Sharif University of Technology, Tehran 14535, Iran.
Mousa KehtariDepartment of Biology, Faculty of Science, University of Tehran, Tehran 14535, Iran.
Seyed Mohsen Ahmadi TaftiColorectal Surgery Research Center, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran 14535, Iran.ORCID 0000-0002-3595-8353
Seyed Hossein Ahmadi TaftiResearch Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center Hospital, Tehran University of Medical Sciences, Tehran 14535, Iran.
Majid Ebrahimi WarkianiSchool of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.

Funding

Australian Research Council DP170103704Australian Research Council DP180103003National Health and Medical Research Council APP1143377
6 · The paper itself

Abstract

Microfluidics is a promising approach for the facile and large-scale fabrication of monodispersed droplets for various applications in biomedicine. This technology has demonstrated great potential to address the limitations of regenerative medicine. Microfluidics provides safe, accurate, reliable, and cost-effective methods for encapsulating different stem cells, gametes, biomaterials, biomolecules, reagents, genes, and nanoparticles inside picoliter-sized droplets or droplet-derived microgels for different applications. Moreover, microenvironments made using such droplets can mimic niches of stem cells for cell therapy purposes, simulate native extracellular matrix (ECM) for tissue engineering applications, and remove challenges in cell encapsulation and three-dimensional (3D) culture methods. The fabrication of droplets using microfluidics also provides controllable microenvironments for manipulating gametes, fertilization, and embryo cultures for reproductive medicine. This review focuses on the relevant studies, and the latest progress in applying droplets in stem cell therapy, tissue engineering, reproductive biology, and gene therapy are separately evaluated. In the end, we discuss the challenges ahead in the field of microfluidics-based droplets for advanced regenerative medicine.

Indexed as

MicrofluidicsRegenerative MedicineBiocompatible MaterialsTissue EngineeringBiocompatible Materialsdropletmicrofluidicsregenerative medicinestem cell therapytissue engineering

Identifiers

PMID35049648
PMCPMC8773546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.